Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration
- PMID: 25010177
- DOI: 10.1001/jamaophthalmol.2014.1768
Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration
Comment in
-
Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.JAMA Ophthalmol. 2014 Jul;132(7):904-5. doi: 10.1001/jamaophthalmol.2014.1783. JAMA Ophthalmol. 2014. PMID: 25010178 Free PMC article. No abstract available.
Comment on
-
Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration.JAMA Ophthalmol. 2014 Feb;132(2):139-41. doi: 10.1001/jamaophthalmol.2013.7443. JAMA Ophthalmol. 2014. PMID: 24309835 No abstract available.
-
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376. JAMA Ophthalmol. 2014. PMID: 24310343 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
